These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 7622815
1. Clinical utility of venlafaxine in comparison with other antidepressants. Lecrubier Y. Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():29-35. PubMed ID: 7622815 [Abstract] [Full Text] [Related]
2. Rapid onset of action of venlafaxine. Montgomery SA. Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814 [Abstract] [Full Text] [Related]
3. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Horst WD, Preskorn SH. J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980 [Abstract] [Full Text] [Related]
4. Safety and tolerance profile of venlafaxine. Danjou P, Hackett D. Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():15-20. PubMed ID: 7622813 [Abstract] [Full Text] [Related]
5. Venlafaxine: a novel antidepressant. Keltner NL. J Psychosoc Nurs Ment Health Serv; 1995 Jan; 33(1):51-3. PubMed ID: 7738872 [Abstract] [Full Text] [Related]
6. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis. van den Broek WW, Mulder PG, van Os E, Birkenhäger TK, Pluijms E, Bruijn JA. J Psychopharmacol; 2009 Aug; 23(6):708-13. PubMed ID: 18562424 [Abstract] [Full Text] [Related]
7. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Möller HJ, Volz HP. Drugs; 1996 Nov; 52(5):625-38. PubMed ID: 9118813 [Abstract] [Full Text] [Related]
8. Safety and tolerability of the new antidepressants. Nelson JC. J Clin Psychiatry; 1997 Nov; 58 Suppl 6():26-31. PubMed ID: 9227670 [Abstract] [Full Text] [Related]
10. Erotomania induced by venlafaxine: a case study. Adamou M, Hale AS. Acta Psychiatr Scand; 2003 Apr; 107(4):314-7. PubMed ID: 12662255 [Abstract] [Full Text] [Related]
11. Pharmacologic profile and efficacy of venlafaxine. Mendlewicz J. Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():5-13. PubMed ID: 7622816 [Abstract] [Full Text] [Related]
12. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Clerc GE, Ruimy P, Verdeau-Pallès J. Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822 [Abstract] [Full Text] [Related]
16. Optimizing antidepressant treatment: efficacy and tolerability. Deakin B, Dursun S. Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607 [Abstract] [Full Text] [Related]
17. Venlafaxine: a novel antidepressant that has a dual mechanism of action. Andrews JM, Ninan PT, Nemeroff CB. Depression; 1996 Jun; 4(2):48-56. PubMed ID: 9160640 [Abstract] [Full Text] [Related]
18. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Kent JM. Lancet; 2000 Mar 11; 355(9207):911-8. PubMed ID: 10752718 [Abstract] [Full Text] [Related]
19. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. Salzman C. J Clin Psychiatry; 1999 Mar 11; 60 Suppl 20():30-3. PubMed ID: 10513856 [Abstract] [Full Text] [Related]